» Articles » PMID: 34093593

Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1

Overview
Journal Front Immunol
Date 2021 Jun 7
PMID 34093593
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Several barriers separate the central nervous system (CNS) from the rest of the body. These barriers are essential for regulating the movement of fluid, ions, molecules, and immune cells into and out of the brain parenchyma. Each CNS barrier is unique and highly dynamic. Endothelial cells, epithelial cells, pericytes, astrocytes, and other cellular constituents each have intricate functions that are essential to sustain the brain's health. Along with damaging neurons, a traumatic brain injury (TBI) also directly insults the CNS barrier-forming cells. Disruption to the barriers first occurs by physical damage to the cells, called the primary injury. Subsequently, during the secondary injury cascade, a further array of molecular and biochemical changes occurs at the barriers. These changes are focused on rebuilding and remodeling, as well as movement of immune cells and waste into and out of the brain. Secondary injury cascades further damage the CNS barriers. Inflammation is central to healthy remodeling of CNS barriers. However, inflammation, as a secondary pathology, also plays a role in the chronic disruption of the barriers' functions after TBI. The goal of this paper is to review the different barriers of the brain, including (1) the blood-brain barrier, (2) the blood-cerebrospinal fluid barrier, (3) the meningeal barrier, (4) the blood-retina barrier, and (5) the brain-lesion border. We then detail the changes at these barriers due to both primary and secondary injury following TBI and indicate areas open for future research and discoveries. Finally, we describe the unique function of the pro-inflammatory cytokine interleukin-1 as a central actor in the inflammatory regulation of CNS barrier function and dysfunction after a TBI.

Citing Articles

Targeting Inflammation After Hemorrhagic Shock as a Molecular and Experimental Journey to Improve Outcomes: A Review.

Meza Monge K, Ardon-Lopez A, Pratap A, Idrovo J Cureus. 2025; 17(1):e77776.

PMID: 39981454 PMC: 11841828. DOI: 10.7759/cureus.77776.


The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Cycloastragenol promotes dorsal column axon regeneration in mice.

Zihan T, Wenwen T, Yanxia M, Saijilafu Front Cell Neurosci. 2025; 18():1424137.

PMID: 39830038 PMC: 11739090. DOI: 10.3389/fncel.2024.1424137.


Neuroinflammatory Response in the Traumatic Brain Injury: An Update.

Kursancew A, Faller C, Bortoluzzi D, Niero L, Brandao B, Danielski L Neurochem Res. 2024; 50(1):64.

PMID: 39718667 DOI: 10.1007/s11064-024-04316-4.


Ependymal cells: roles in central nervous system infections and therapeutic application.

Xie S, Li F J Neuroinflammation. 2024; 21(1):255.

PMID: 39385253 PMC: 11465851. DOI: 10.1186/s12974-024-03240-2.


References
1.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

2.
Erickson K, Sundstrom J, Antonetti D . Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis. 2007; 10(2):103-17. DOI: 10.1007/s10456-007-9067-z. View

3.
Perez-Polo J, Rea H, Johnson K, Parsley M, Unabia G, Xu G . Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury. J Neurosci Res. 2015; 94(1):27-38. DOI: 10.1002/jnr.23617. View

4.
Bronson R, Bertolami C, Siebert E . Modulation of fibroblast growth and glycosaminoglycan synthesis by interleukin-1. Coll Relat Res. 1987; 7(5):323-32. DOI: 10.1016/s0174-173x(87)80025-0. View

5.
Kerr N, Lee S, Perez-Barcena J, Crespi C, Ibanez J, Ross Bullock M . Inflammasome proteins as biomarkers of traumatic brain injury. PLoS One. 2019; 13(12):e0210128. PMC: 6312377. DOI: 10.1371/journal.pone.0210128. View